State Street Corp 10x Genomics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,750,643 shares of TXG stock, worth $25.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,750,643
Previous 1,634,109 7.13%
Holding current value
$25.7 Million
Previous $31.8 Million 24.37%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$15.71 - $23.49 $1.83 Million - $2.74 Million
116,534 Added 7.13%
1,750,643 $39.5 Million
Q2 2024

Aug 14, 2024
BUY
$19.45 - $37.37 $941,516 - $1.81 Million
48,407 Added 3.05%
1,634,109 $31.8 Million
Q1 2024

May 15, 2024
BUY
$36.08 - $54.3 $955,181 - $1.44 Million
26,474 Added 1.7%
1,585,702 $59.5 Million
Q4 2023

Feb 14, 2024
BUY
$34.32 - $57.55 $3.38 Million - $5.67 Million
98,591 Added 6.75%
1,559,228 $87.3 Million
Q3 2023

Nov 14, 2023
BUY
$40.86 - $62.98 $1.15 Million - $1.77 Million
28,100 Added 1.96%
1,460,637 $60.3 Million
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $1.03 Million - $1.19 Million
20,190 Added 1.43%
1,432,537 $80 Million
Q1 2023

May 15, 2023
BUY
$35.33 - $55.79 $2.35 Million - $3.72 Million
66,598 Added 4.95%
1,412,347 $78.8 Million
Q4 2022

Feb 14, 2023
SELL
$24.4 - $41.3 $443,299 - $750,338
-18,168 Reduced 1.33%
1,345,749 $49 Million
Q3 2022

Nov 15, 2022
BUY
$28.48 - $52.59 $760,273 - $1.4 Million
26,695 Added 2.0%
1,363,917 $38.8 Million
Q2 2022

Aug 15, 2022
SELL
$36.95 - $82.41 $12.8 Million - $28.5 Million
-345,543 Reduced 20.53%
1,337,222 $60.5 Million
Q1 2022

May 16, 2022
BUY
$55.7 - $145.79 $910,305 - $2.38 Million
16,343 Added 0.98%
1,682,765 $128 Million
Q4 2021

Feb 14, 2022
SELL
$135.05 - $182.59 $163,950 - $221,664
-1,214 Reduced 0.07%
1,666,422 $248 Million
Q3 2021

Nov 15, 2021
BUY
$145.58 - $192.14 $10.7 Million - $14.1 Million
73,616 Added 4.62%
1,667,636 $243 Million
Q2 2021

Aug 16, 2021
BUY
$134.22 - $202.37 $62.2 Million - $93.8 Million
463,597 Added 41.01%
1,594,020 $312 Million
Q1 2021

May 17, 2021
BUY
$140.25 - $196.86 $8.26 Million - $11.6 Million
58,876 Added 5.49%
1,130,423 $205 Million
Q4 2020

Feb 16, 2021
BUY
$126.47 - $163.7 $64.3 Million - $83.2 Million
508,153 Added 90.19%
1,071,547 $152 Million
Q3 2020

Nov 10, 2020
BUY
$87.44 - $125.0 $6.24 Million - $8.93 Million
71,404 Added 14.51%
563,394 $70.2 Million
Q2 2020

Aug 14, 2020
BUY
$58.39 - $89.31 $28.3 Million - $43.3 Million
484,890 Added 6829.44%
491,990 $43.9 Million
Q1 2020

May 11, 2020
BUY
$51.57 - $106.62 $366,147 - $757,002
7,100 New
7,100 $442,000

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.39B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email